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Genomic technologies are redeﬁning the understanding of geno-
type–phenotype relationships and over the past decade, many
bioinformatics algorithms have been developed to predict func-
tional consequences of single nucleotide variants. This article
presents the data from a comprehensive computational workﬂow
adopted to assess the biomedical impact of the DNA variants
resulting from the experimental study “Molecular analysis of sar-
comeric and non-sarcomeric genes in patients with hypertrophic
cardiomyopathy” (Bottillo et al., 2016) [1]. Several different inde-
pendently methods were employed to predict the functional
consequences of alleles that result in amino acid substitutions, to
study the effect of some DNA variants over the splicing process andvier Inc. This is an open access article under the CC BY license
/j.gene.2015.11.048
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I. Bottillo et al. / Data in Brief 7 (2016) 607–613608to investigate the impact of a sequence variant with respect to the
evolutionary conservation.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaIn silico predictions of DNA variantsype of data Tables, ﬁgures
ow data was
acquiredPrediction tools: SIFT, Polyphen HDIV, Polyphen HVAR, Provean, LRT, Muta-
tion Taster, Mutation Assessor, FATHMM, RadialSVM, LR, CADD, HSF,
GERPþþ , PhyloP placental, PhyloP veterbrate, SiPhyMolecular Modelingata format Processed, ﬁltered and analyzed
xperimental
factorsGenomic DNA from peripheral blood was tested by next generation
sequencing on Ion Torrent PGM (ThermoFisher, Carlsbad, CA, USA) with a
custom cardiomyopathy panelxperimental
featuresThe identiﬁed rare (Minor Allele Frequency r0,01) non-synonymous DNA
changes were subjected to different in silico predictionsata source
locationRome, Italyata accessibility These data are with this articleD
Value of the data
 These data delineate a prompt informatic pipeline for the prioritization of the most likely patho-
genetic DNA variants in a clinical context.
 These data are supportive for the researchers to evaluate the prevalence of sarcomeric and non-
sarcomeric gene variants in hypertrophic cardiomyopathy.
 The described computational strategy is helpful to researchers for the rapid interpretation of
Variants of Unknown Signiﬁcance (VUS) implicated in rare, common and complex diseases.1. Data
Here we report the in silico predictions data of the non-synonymous changes found in 41 HCM
patients and in 3 HCM-related cases [1] (Table 1).2. Experimental design, materials and methods
2.1. Analysis of the nucleotides' evolutionary conservation
Nucleotide-speciﬁc estimates of evolutionary constraint were explored by (i) GERPþþ (Genomic
Evolutionary Rate Proﬁling); (ii) PhyloP placental; (iii) PhyloP veterbrate and (iv) SiPhy.
2..2. Analysis of the splicing variants
The analysis of intronic variants leading to splicing defects was tested by Human Splicing Finder
(HSF) 3.0.
Table 1
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The effect of missense changes on the structure and function of a human protein was predicted by:
(i) SIFT (Sorting Intolerant From Tolerant), (ii) PolyPhen-2 (Polymorphism Phenotyping v2) HDIV, that
identiﬁes human damaging mutations by assuming differences between human proteins and their closely
related mammalian homologs as non-damaging; (iii) PolyPhen-2 HVAR, that identiﬁes human disease-
causing mutations by assuming common human nsSNPs as non-damaging; (iv) Provean (Protein Varia-
tion Effect Analyzer); (v) LRT (Likelihood Ratio Test) that identiﬁes conserved amino acid positions and
deleterious mutations using a comparative genomics data set of multiple vertebrate species; (vi) Mutation
Taster; (vii) Mutation Assessor; (viii) FATHMM (Functional Analysis through Hidden Markov Models); (ix)
RadialSVM (Radial Support Vector Machine); (x) LRT (Logistic Regression Test); (xi) CADD v1.3 (Combined
Annotation–Dependent Depletion), a method for objectively integrating many diverse annotations into a
single measure (C score) for each variant; and (xii) molecular modeling.Fig. 1. Structural comparison of wild-type and mutant forms for (a) FLH2 A37S; (b) LAMA4 E1646G; (c) MYH6 R23H; (d) MYH7
A226T; (e) MYH7 R143Q; (f) MYOM1 R711H; (g) PKP2 R767S; (h) RYR2 E1127G; (i) RYR2 R485Q. The mutation is indicated in
white. The predicted structural effects of mutations are: (a, d) steric hindrance (red circles); (b) local misfolding of linker domain
(orange); (c, e, f, g) loss of important inter-residues contacts; (h) loss of a π-anion interaction; (i) loss of a π-cation interaction.
Fig. 2. Effects of nsSNVs for: (a) the cadherin domain of DSC2. The mutant R199C in the cadherin domain of DSC2 is predicted to
introduce a disulﬁde bond with the near Cys197 residue (Cα-Cα distance 6Âe), and possibly to result in local misfolding of the
cadherin domain; (b) the melibiase domain of GLA. Mutant N215S of the melibiase domain of GLA results in the loss of a glycosylated
site probably affecting the protein structure and/or function; (c) the FGF13 interaction domain of SCN5. Mutation I869F localizes on a
solvent-exposed hydrophobic path of the domain of interaction with ﬁbroblast growth factor 13 (FGF13). The I869F mutation could
affect the recognition of the FGF13 protein; (d) the Na-Channel of SCN5. The mutant D872N results in the loss of a negative charge that
is approximately located at the Na-channel domain of SCN5, probably affecting cations conductance of the channel. The approximate
position of the negatively charged Asp872 residue is shown in red, in each of the four protein subunits forming the channel.
I. Bottillo et al. / Data in Brief 7 (2016) 607–613612Regarding the molecular modeling, protein structure were experimentally determined by X-ray
crystallography, or were inferred by homology modeling means (i.e., availability of a structural
template with percentage of identity 4 20%). Protein models were built using the homology mod-
eling approach implemented in modeler-9 package [2]. PSI-BLAST was used to ﬁnd suitable structural
templates for each sequence to model [3]. The sequences of each protein target to model and its
structural template were then aligned by using the program CLUSTALW [4] and manually manipu-
lated to optimize the matching of several characteristics, including the observed and predicted sec-
ondary structural elements, the hydrophobic regions in the three-dimensional structures, the struc-
turally and functionally conserved residues, and indel regions in the structures. Then, ten different
models were built for each target protein and evaluated using several criteria. The model displaying
the lowest objective function [5], which measures the extent of violation of constraints from the
structural templates, was taken as the representative model. Superimposition and root-mean-square
deviation (RMSD) calculation of Cα traces of the 10 models were performed to detect the most
variable and therefore less reliable modeled regions. These invariably corresponded to loop elements.
I. Bottillo et al. / Data in Brief 7 (2016) 607–613 613Procheck [6] was used to monitor the stereochemical quality of the representative models, whereas
ProsaII [7] was used to measure the overall protein quality in packing and solvent exposure. Muta-
tions on protein structures was carried out using the “Mutate model” script implemented in modeler-
9 package [2]. The script takes as input a given three-dimensional structure of a protein (experi-
mentally determined or predicted), and mutates a single residue. The residue sidechain's position is
then optimized by energy minimization and reﬁned by molecular dynamics simulations. Prediction of
protein stability upon mutation was carried out using the DUET server [8]. Sequence identity between
the modeled domain and its closest template ranged from 23% (Laminin G-like domain of LAMA4), to
nearly 95% (N-terminal globular head domain of VCL). However, in spite of the low value of sequence
identity measured in some cases, all of the models resulted in a good overall quality (Prosa Z-score
o2.00), except for CALR3 and SCN5. Given the short length of the predicted PB035848 domain of
CALR3 (residues 294-347) and its sequence identity with its template (61%), the measured Prosa Z-
score (1.93) nonetheless indicated a model of quality comparable to a Nuclear Magnetic Resonance
(NMR) structure [7] ( Figs. 1 and 2).Acknowledgments
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